Company / Current Assets per Share
Insight Molecular Diagnostics Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.88
FY2025
5-year range
$0.28 / $1.80
FY2021-FY2025
Trend
-38.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 6 years, ranging from $0.16 in FY2020 to $1.80 in FY2023.
Based on SEC 10-K filings.
0.88 in FY2025 with a 5-year CAGR of +40.2%.
Declined from $1.80 to $0.88 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +46.9%
- 5-Year CAGR
- +40.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 38.4% year-over-year.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.88 | -38.4% |
| FY2024 | $1.42 | -21.1% |
| FY2023 | $1.80 | +551.4% |
| FY2022 | $0.28 | -51.1% |
| FY2021 | $0.57 | +250.1% |
| FY2020 | $0.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026